Sophie Deckert-Tartare

Nice, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway.

Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway.

Journal: Oncogenesis
Published: August 25, 2025

USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization.

USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization.

Journal: Cell reports
Published: January 29, 2025

Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis.

Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis.

Journal: Neurology and therapy
Published: October 24, 2022

Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance.

Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance.

Journal: Frontiers in oncology
Published: April 20, 2022

The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.

The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.

Journal: EMBO reports
Published: March 17, 2022

The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance.

The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance.

Journal: Oncogenesis
Published: March 07, 2022

Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma.

Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma.

Journal: EMBO molecular medicine
Published: October 16, 2021

Deubiquitinase Inhibitors Impair Leukemic Cell Migration Through Cofilin Oxidation and Alteration of Actin Reorganization.

Deubiquitinase Inhibitors Impair Leukemic Cell Migration Through Cofilin Oxidation and Alteration of Actin Reorganization.

Journal: Frontiers in pharmacology
Published: September 16, 2021

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.

Journal: Oncogene
Published: May 05, 2021

Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells.

Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells.

Journal: Cancer research
Published: February 12, 2021

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.

Journal: Theranostics
Published: January 15, 2021

Melanoma therapeutic escape: the biomechanical track

Melanoma therapeutic escape: the biomechanical track

Journal: Medecine sciences : M/S
Published: November 05, 2020
Showing 1-12 of 33

Last Updated: 09/26/2026